论文部分内容阅读
目的：探析阿伐他汀与氯吡格雷对超敏C反应蛋白及预后的影响。方法选取我院收治的124例心绞痛患者为研究对象，在常规用药的基础上联合应用阿伐他汀与氯吡格雷，观察其对患者血清超敏C反应蛋白（hs-CRP）及预后的影响。结果相较与常规药物治疗的对照组患者其超敏C反应蛋白水平下降程度更为显著（P＜0.05），总的心血管事件发生率也显著降低（P＜0.05）。结论在心绞痛患者常规治疗中加用阿伐他汀与氯吡格雷，可显著降低患者的血清超敏C反应蛋白，从而减少心血管事件的发生率。“,”Objective to analysis the laval statin with clopidogrel for hypersensitive c-reactive protein and prognosis. Methods select our hospital 124 cases of angina pectoris patients as the research object, on the basis of conventional drugs combined use of atonrastatin, statin and clopidogrel, observe the serum of patients with allergic c-reactive protein (hs - CRP) and prognosis. Results in comparison with conventional drug treatment of the control group patients with its hypersensitive c-reactive protein levels drop degree is more signiifcantly (P < 0.05), the total incidence of cardiovascular events also signiifcantly lower (P < 0.05). Conclusion in patients with angina pectoris, o routine treatment added with laval statin with clopidogrel, can signiifcantly reduce the patient’s serum hypersensitive c-reactive protein, thereby reducing the incidence of cardiovascular events.